Hongxiang Wei

541 citations
14 papers · 434 indexed · h-index 8
Topics
RNA Interference and Gene Delivery (3 papers)Extracellular vesicles in disease (2 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers)
Partner nations
ChinaRussiaUnited States

In The Last Decade

Hongxiang Wei

13 papers receiving 431 citations

Peers

Hongxiang Wei
Comparison fields: 5 of 64
  • Molecular Biology 364
  • Cancer Research 204
  • Biomedical Engineering 82
  • Oncology 45
  • Biomaterials 39
Replace Song-pei Li with:
Song-pei Li China
Zhimin Han China
Renfeng Liu China
Yuanmin Zhang China
Doulathunnisa Jaffar Ali China
Ke Si China
Narges Mardi Iran
Byeong Hoon Oh South Korea
Baoqing Tian China
Hong Jin China
Hongxiang Wei relative to Song-pei Li China Song-pei Li's profile →
Citations per field
00.5×1.7×
Song-pei Li · 1×
Citations per year

Countries citing papers authored by Hongxiang Wei

Since Specialization
Citations

This map shows the geographic impact of Hongxiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxiang Wei more than expected).

Fields of papers citing papers by Hongxiang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxiang Wei. The network helps show where Hongxiang Wei may publish in the future.

Co-authorship network of co-authors of Hongxiang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxiang Wei. A scholar is included among the top collaborators of Hongxiang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxiang Wei. Hongxiang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 4
3 81
4 12
5 23
6 6
7 8
8 7
9 4
10 1
11 16
12 14
13
Gasdermin D expression and clinicopathologic outcome in primary osteosarcoma patients.
9
14 249

About Hongxiang Wei

Hongxiang Wei is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 14 papers that have together received 434 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Extracellular vesicles in disease (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Cancer Research (204 citations), Molecular Biology (364 citations) and Biomaterials (39 citations). Hongxiang Wei has collaborated with scholars based in China, Russia and United States. Frequent co-authors include Shenglin Wang, Guang‐Xian Zhong, Chaoyang Wu, Jianhua Lin, Jinyuan Chen, Zhoujie Liu, Xia Zhu, Yunqing Wang, Jin-Yuan Chen and Fei Chen. Their work appears in journals such as Analytical Chemistry, The Analyst and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026